EPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIX
Portfolio Pulse from
Rosen Law Firm is urging investors of ESSA Pharma Inc. (NASDAQ: EPIX) who purchased securities between December 12, 2023, and October 31, 2024, to secure counsel before the March 25, 2025, lead plaintiff deadline in a securities class action.
March 17, 2025 | 8:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is involved in a securities class action lawsuit, with a lead plaintiff deadline on March 25, 2025. Investors who purchased shares during the specified period are encouraged to secure legal counsel.
The involvement in a securities class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and reputational damage. The urgency of the March 25 deadline suggests significant investor interest and potential impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100